crispr mitochondrial editing
5 Fatal Gaps in Longevity Science Gene Therapy Ethics
In 2024, researchers reported that CRISPR could edit up to 80% of known pathogenic mitochondrial mutations, but the moral right to rewrite our power plants remains hotly debated. The promise of halting age-related decline collides with questions about consent, equity, and unforeseen biological fallout. Medical Disclaimer: This article is for